- Home
- PULM vs CLDI Comparison
PULM vs CLDI Comparison
Compare PULM & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- CLDI
- Stock Information
- Founded
- PULM 2003
- CLDI 2014
- Country
- PULM United States
- CLDI United States
- Employees
- PULM 22
- CLDI N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PULM Health Care
- CLDI Health Care
- Exchange
- PULM Nasdaq
- CLDI Nasdaq
- Market Cap
- PULM 21.9M
- CLDI 18.1M
- IPO Year
- PULM N/A
- CLDI N/A
- Fundamental
- Price
- PULM $5.80
- CLDI $1.34
- Analyst Decision
- PULM
- CLDI Strong Buy
- Analyst Count
- PULM 0
- CLDI 3
- Target Price
- PULM N/A
- CLDI $16.67
- AVG Volume (30 Days)
- PULM 131.2K
- CLDI 1.1M
- Earning Date
- PULM 11-08-2024
- CLDI 11-12-2024
- Dividend Yield
- PULM N/A
- CLDI N/A
- EPS Growth
- PULM N/A
- CLDI N/A
- EPS
- PULM N/A
- CLDI N/A
- Revenue
- PULM $10,005,000.00
- CLDI N/A
- Revenue This Year
- PULM N/A
- CLDI N/A
- Revenue Next Year
- PULM $1.00
- CLDI N/A
- P/E Ratio
- PULM N/A
- CLDI N/A
- Revenue Growth
- PULM 47.05
- CLDI N/A
- 52 Week Low
- PULM $1.55
- CLDI $0.14
- 52 Week High
- PULM $8.44
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- PULM 57.17
- CLDI 36.87
- Support Level
- PULM $5.80
- CLDI $1.27
- Resistance Level
- PULM $6.57
- CLDI $2.17
- Average True Range (ATR)
- PULM 0.43
- CLDI 0.19
- MACD
- PULM -0.14
- CLDI -0.09
- Stochastic Oscillator
- PULM 36.69
- CLDI 13.33
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.